Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ... Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. Show more
Board of Directors approves increase in quarterly cash dividend to $0.43 per share Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash...
IBRANCE is the first CDK4/6 inhibitor to show benefit in a large Phase 3 trial in first-line HR+, HER2+ metastatic breast cancer, in combination with anti-HER2 and endocrine therapy Pfizer Inc...
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 8:30 a.m. EST on Tuesday, December 17, 2024. The...
– Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate: 62.5%; overall response rate: 26.7%) in patients previously treated with a CDK4/6...
Pfizer Inc. (NYSE: PFE) will highlight the latest advancements from its growing hematology and breast cancer portfolios at the American Society of Hematology (ASH) Annual Meeting & Exposition...
Chris Boshoff to lead all Research and Development functions including Oncology Oncology Unit end-to-end structure to remain intact, reporting to Boshoff Roger Dansey to become Interim Chief...
In the EU, HYMPAVZI is the first once-weekly subcutaneous treatment approved for eligible people living with severe hemophilia B and the first to be administered via a pre-filled pen or syringe...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.34 | -1.3209013209 | 25.74 | 26.44 | 25.126 | 37282610 | 25.5875227 | CS |
| 4 | -0.3 | -1.1673151751 | 25.7 | 26.45 | 24.48 | 45690105 | 25.40353269 | CS |
| 12 | -4.14 | -14.0148950575 | 29.54 | 30.43 | 24.48 | 39680708 | 27.24221525 | CS |
| 26 | -2.1 | -7.63636363636 | 27.5 | 31.54 | 24.48 | 34976755 | 28.09845672 | CS |
| 52 | -0.88 | -3.34855403349 | 26.28 | 31.54 | 24.48 | 39402891 | 27.79230078 | CS |
| 156 | -28.04 | -52.4700598802 | 53.44 | 61.71 | 24.48 | 30445004 | 37.1542475 | CS |
| 260 | -13.15 | -34.1115434501 | 38.55 | 61.71 | 24.48 | 30998893 | 37.9652339 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
